Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01243229 · ClinicalTrials.gov registry record
Genetic Analysis of Congenital Diaphragmatic Disorders
A clinical trial, sponsored by University of Utah.
- Completed
- Registry status
- 305
- Enrollment target
NCT01243229 is a clinical trial that has completed, run by University of Utah. The registered enrollment target is 305 participants.
The verdict
NCT01243229 has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- 305 participants
- Enrollment target
Study Summary
The purpose of this study is to understand the genetic causes of congenital diaphragmatic disorders (CDD), namely congenital diaphragmatic hernia (CDH), eventration and hiatal hernia. Specifically, the investigators plan to: 1. Ascertain informative families and sporadic cases with congenital diaphragmatic disorders and obtain appropriate phenotypic data and genetic material (peripheral blood and/or diaphragm tissue sample). 2. Localize the gene(s) for CDD to specific chromosomal segments using linkage analysis, and determine the role of somatic mutations in CDD. 3. Isolate and characterize genes involved in the pathogenesis of CDD. 4. Develop molecular markers that will facilitate accurate diagnosis (including prenatal diagnosis) and permit correlation of phenotypic variation with specific mutations. 5. Compare RNA-sequencing from tissue samples of children without CDH to those children with CDH.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 305 participants |
| Start Date | 2010-10 |
| Est. Completion | 2021-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01243229
The ClinicalTrials.gov registry entry for NCT01243229 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 305 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01243229 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01243229 about?
NCT01243229 is a clinical study titled "Genetic Analysis of Congenital Diaphragmatic Disorders". The purpose of this study is to understand the genetic causes of congenital diaphragmatic disorders (CDD), namely congenital diaphragmatic hernia (CDH), eventration and hiatal hernia. Specifically, the investigators plan to: 1. Ascertain informative families and sporadic cases with congenital diap...
What is the current status of trial NCT01243229?
This trial is currently completed. The enrollment target is 305 participants. The study started on 2010-10. Estimated completion is 2021-06-01.
Who is sponsoring clinical trial NCT01243229?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.